A novel protease from Bacillus clausii UBBC07, a healthful solution against diarrhea-causing pathogens

Jyoti Guleria Mohammad Rashid Khan Minhaj Ahmad Khan   

Open Access   

Published:  Aug 20, 2024

DOI: 10.7324/JABB.2024.200074
Abstract

Present treatments for gastroenteritis include the use of antibiotics, probiotics, or spore solutions, which are derived mainly from microbial communities. To avoid multidrug resistance, probiotic bacteria like Bacillus clausii can be of great importance. In the present study, isolation, purification, and physicochemical characterization and bactericidal effect of an extracellularly secreted, novel protease was performed from B. clausii strain UBBC07. In vitro assays, including well-diffusion assay and gel-overlay assay, were used to confirm the anti-diarrheal potential of isolated protein. Molecular weight and the sequence of purified protease were identified by LC-MS/MS. The purified protein’s molecular mass was 23,460 Da. Peptide mass fingerprinting confirmed the novel protein to be a protease with 36% homology to the existing Din b family protein, with strong metalloprotease-like properties. Physicochemical analysis showed that the protein was stable at a broad range of temperatures and pH and retained up to 50% activity at very high temperatures and extreme pH. The efficacy of protein was tested against two major diarrhea-causing pathogens (Bacillus cereus and Salmonella enterica), and the minimum inhibitory concentration obtained was 9.78 μM. The bactericidal effect of purified protein was assayed using time-kill kinetics, where 105 CFU/ml of B. cereus and S. enterica cells were killed in 4 h. Microscopic analysis of Gram-stained bacterial cells also showed debris formation after protease treatment. Researchers have described the impact of resistant bacteria on the long-term prevalence of diarrhea. This situation inspires researchers to come up with more cost-effective and high-efficacy alternatives like proteases to treat this disease.


Keyword:     Bacillus clausii Gut disorders Metalloprotease LC-MS/MS Spores Immunity


Citation:

Guleria J, Khan MR, Khan MA. A novel protease from Bacillus clausii UBBC07, a healthful solution against diarrhea-causing pathogens. J App Biol Biotech. 2024. Online First. http://doi.org/10.7324/JABB.2024.200074

Copyright: Author(s). This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike license.

HTML Full Text
Reference

1. Caminero A, Guzman M, Libertucci J, Lomax AE. The emerging roles of bacterial proteases in intestinal diseases. Gut Microbes. 2023;15:1, 2181922, DOI: https://doi.org/10.1080/19490976.2023.2181922.

2. Kriaa A, Jablaoui A, Rhimi S, Soussou S, Mkaouar H, Mariaule V, et al. SP-1, a Serine protease from the gut microbiota, influences colitis and drives intestinal dysbiosis in mice. Cells. 2021; 10(10):2658.

https://doi.org/10.3390/cells10102658

3. Souza D, Bonnart C, Tapias NS, Marcellin M, Gilmore B, Alric C, et al. Functional proteomic profiling of secreted serine proteases in health and inflammatory bowel disease. Sci Rep. 2018; 8:7834. https://doi.org/10.1038/s41598-018-26282-y

4. Singh T, Kaur G, Kaur A. Dysbiosis—an etiological factor for cardiovascular diseases and the therapeutic benefits of gut microflora. Adv Gut Microb Res. 2023; Article ID 7451554, 8 pages, https://doi.org/10.1155/2023/7451554

5. Burgers K, Lindberg B and Bevis JZ. Chronic diarrhea in adults: evaluation and differential diagnosis. Am Fam Phys. 2020; 101(8). https://www.aafp.org/afp/2020/0415/p472-s1.html

6. Edogawa S, Edwinson AL, Peters SA, Chikkamenahalli LL, Sundt W, Graves S, et al. Serine proteases as luminal mediators of intestinal barrier dysfunction and symptom severity in IBS. Gut. 2020;69:62– 73. doi: https://doi.org/10.1136/gutjnl-2018-317416.

7. Moayyedi P, Simren M, Bercik P. Evidence-based and mechanistic insights into exclusion diets for IBS. Nat Rev Gastroenterol Hepatol. 2020;17(7):406-13.

https://doi.org/10.1038/s41575-020-0270-3.

8. Sto?ca RM, Moscov?c? M, Tomulescu C, C???r?c? A, B?beanu N, Popa O, et al. Antimicrobial compounds of the genus Bacillus: a review. Roman Biotechnol Lett. 2019;24(6):1111-9. DOI: https://doi.org/10.25083/rbl/24.6/1111.1119

9. Jovanovic J, Ornelis VFM., Madder A, Rajkovic A. Bacillus cereus food intoxication and toxic infection. Comp Rev Food Sci Food Saf. 2021. https://doi.org/10.1111/1541-4337.12785

10. Khokhlova E, Colom J, Simon A, Mazhar S, García-Lainez G, Llopis S, et al. Immunomodulatory and antioxidant properties of a novel potential probiotic Bacillus clausii CSI08. Microorganisms. 2024;11(2):240. https://doi.org/10.3390/microorganisms11020240

11. Schiller LR, Pardi DS, Sellin JH. Chronic diarrhea: diagnosis and management. Clin Gastroenterol Hepatol. 2017;15(2):182–93.e3.

12. Ripert G, Racedo SM, Elie AM, Jacquot C, Bressollieret P, Urdaci MC, et al. Secreted compounds of the probiotic Bacillus clausii strain O/C inhibit the cytotoxic effects induced by Clostridium difficile and Bacillus cereus toxins. Antimicrob Agents Chemother. 2016;60:3445-54. https://doi.org/10.1128/AAC.02815-15

13. Guillier L, Thébault A, Fravalo P, Gras L, Silva N, David J, et al. Risk factors for sporadic salmonellosis: a systematic review and meta-analysis. Microbial Risk Anal. 2021;17:100138. ISSN 2352-3522. https://doi.org/10.1016/j.mran.2020.100138

14. Ahire JJ, Kashikar MS, Madempudi RS. Comparative accounts of probiotic properties of spore and vegetative cells of Bacillus clausii UBBC07 and in silico analysis of probiotic function. 3 Biotech. 2021;11:116.

15. De Oliveira DMP, Forde BM, Kidd TJ, Harris PNA, Schembri MA, Beatson SA, et al. Antimicrobial resistance in ESKAPE pathogens. Clin Microbiol Rev. 2020;33(3):e00181-19. https://doi.org/10.1128/cmr.00181-19

16. Maqbool H, Visnuvinayagam S, Zynudheen A, Safeena MP, Kumar S. Antibacterial activity of beetroot peel and whole radish extract by modified well diffusion assay. Int J Curr Microbiol Appl Sci. 2020. January, DOI: 10.20546/ijcmas.2020.901.135.

17. Liu Z, Guan X, Zhong X, Zhou X, Yang F. Bacillus velezensis DP-2 isolated from Douchi and its application in soybean meal fermentation. J Sci Food Agricult. 2020.

https://doi.org/10.1002/jsfa.10801.

18. Nargotra P, Sharma V, Sharma S, Bangotra R, Bajaj BK, Purification of an ionic liquid stable cellulase from Aspergillus aculeatus PN14 with potential for biomass refining. Environ Sustain. 2022;5:313-23. https://doi.org/10.1007/s42398-022-00232-x

19. Sakuma C, Tomioka Y, Li C, Shibata T, Nakagawa M, Kurosawa Y, et al. Analysis of protein denaturation, aggregation, and post-translational modification by agarose native gel electrophoresis. Int J Biol Macromol. 2021; 172: 589–596. ISSN 0141-8130. https://doi.org/10.1016/j.ijbiomac.2021.01.075

20. Noor Z, Ahn SB, Baker MS, Ranganathan S, Mohamedali A. Mass spectrometry-based protein identification in proteomics – a review. Brief Bioinform. 2021; 22(2):1620–38. https://doi.org/10.1093/bib/bbz163

21. Yi L, Luo L, Lu X. Efficient exploitation of multiple novel bacteriocins by a combination of complete genome and peptidome. Front Microbiol. 2018;9:1567. https://doi.org/10.3389/fmicb.2018.01567.

22. Taggar R, Jangra M, Dwivedi A, Bansal K, Patil P. Bacteriocin isolated from the natural inhabitant of Allium cepa against Staphylococcus aureus. World J Microbiol Biotechnol. 2021; 37:20. https://doi.org/10.1007/s11274-020-02989-x

23. Jangra M, Kaur M, Tambat R, Rana R, Mauryaet SK, Khatri N, et al. Tridecaptin M, a new variant discovered in mud bacterium, shows activity against colistin and extremely drug-resistant Enterobacteriaceae. Antimicrob Agents Chemother. 2019;63:6. https://doi.org/10.1128/AAC.00338-19

24. Wilson C, Lukowicz R, Merchant S, Valquier-Flynn H, Caballero J, Sandoval J, et al. Quantitative and qualitative assessment methods for biofilm growth: a mini-review. Res Rev J Eng Technol. 2017;6(4).

25. Wei G, Darwish G, Oppenheim FG, Schuppan D, Helmerhorst EJ. Commensal bacterium Rothia aeria degrades and detoxifies gluten via a highly effective subtilisin enzyme. Nutrients. 2020; 12:3724. doi: https://doi.org/10.3390/nu12123724.49

26. Gioia M, Ciaccio C, Calligari P, De Simone G, Sbardella D, Tundo G, et al. Role of proteolytic enzymes in the COVID-19 infection and promising therapeutic approaches. Biochem Pharmacol. 2020;182:114225. ISSN 0006-2952, https://doi.org/10.1016/j. bcp.2020.114225.

27. Bueno A, Abreu A, Guarner, F, et al. Bacillus clausii for gastrointestinal disorders: a narrative literature review. Adv Therapeut. 2022;39:4854–74. https://doi.org/10.1007/s12325-022-02285-0

28. Dubey S, Sharma N, Thakur S, Patel R, Reddy BM, Bacillus cereus food poisoning in Indian perspective: a review. Pharma Innov J. 2021;10(9):970-5.

29. Zhang J, Peng Z, Chen K, Zhan Z, Shen H, Feng S, et al. Genomic characterization of Salmonella enterica serovar Weltevreden associated with human diarrhea. Microbiol Spectr. 2023;11:e03542- 22. https://doi.org/10.1128/spectrum.03542-22

30. Aquaro S, Borrajo A, Pellegrino M, Svicher V. Mechanisms underlying antiretroviral drugs in different cellular reservoirs with a focus on macrophages. Virulence. 2020; 11(1):400–13. doi: https://doi.org/10.1080/21505594.2020.1760443

31. Caminero A, Guzman M, Libertucci J Lomax AE. The emerging roles of bacterial proteases in intestinal diseases. Gut Microb. 2023; 15:1. 2181922. DOI: https://doi.org/10.1080/19490976.2023.2181922

Article Metrics
13 Views 9 Downloads 22 Total

Year

Month

Related Search

By author names